Centice Corporation launches partner program for PASS Rx system availability

NewsGuard 100/100 Score

Centice Corporation®, a pioneer in chemical verification of dispensed drug prescriptions and the manufacturer of the PASS Rx system, today launched a partner program to make available the PASS Rx® system to companies wanting to include unique prescription verification technology into workflow projects. In addition to preferred pricing and reseller discounts, the program offers industry partners technical assistance and integration expertise for pharmacy and hospital projects. OEM partners are offered flexible branding options.

“We feel our chemical verification technology is the benchmark of the industry for mitigating drug dispensing risks”

"We feel our chemical verification technology is the benchmark of the industry for mitigating drug dispensing risks", said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice, "This new program responds to the increasing demand for our technology in a total quality assurance system."

VIP Computer Systems, Inc., based in Hillsborough, N.C., is a leading Pharmacy Management System (PMS) provider with over 300 independent pharmacy customers. Jim Hall, CEO and President of VIP Computer Systems, says "VIP delivers software that streamlines pharmacy operations and is flexible enough to adapt to individual pharmacist's workflow. Our commitment to industry leading customer service includes integrating with other vendors. The Centice Pass Rx solution is part of a quality assurance system that can leverage VIP's Total Drug File databases to provide extra drug verification for customers."

Centice will be exhibiting at the NACDS Pharmacy & Technology Conference in San Diego, CA from August 28-31, 2010 in booth #1419. Demonstrations will be provided as well as a chance to win a Kindle. If you would like to schedule a meeting with a Centice executive, please contact Sarah Mepham at [email protected].

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy